Lv4
576 积分 2021-12-19 加入
Associations of liver fat content with cardiometabolic phenotypes and outcomes in a multi‐ethnic population: Results from the Dallas Heart Study
23天前
已完结
Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy
2个月前
已完结
Staging prediabetes and type 2 diabetes: the time to start is now
3个月前
已完结
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease
4个月前
已完结
Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLD
4个月前
已完结
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
4个月前
已完结
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
4个月前
已完结
HbA1c: a review of non-glycaemic variables
4个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease
4个月前
已完结
Type 2 diabetes, prediabetes, and MASLD: who and when to screen and how to treat?
5个月前
已完结
皖公网安备34019202002308
